Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion.

Burt Solorzano CM, McCartney CR, Blank SK, Knudsen KL, Marshall JC.

BJOG. 2010 Jan;117(2):143-9. doi: 10.1111/j.1471-0528.2009.02383.x. No abstract available.

2.

Reproductive endocrinology of adolescent polycystic ovary syndrome.

Shayya R, Chang RJ.

BJOG. 2010 Jan;117(2):150-5. doi: 10.1111/j.1471-0528.2009.02421.x. Review.

3.
4.

Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.

Blank SK, McCartney CR, Helm KD, Marshall JC.

Semin Reprod Med. 2007 Sep;25(5):352-9. Review.

PMID:
17710731
5.

The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.

Blank SK, McCartney CR, Marshall JC.

Hum Reprod Update. 2006 Jul-Aug;12(4):351-61. Epub 2006 May 2. Review.

PMID:
16670102
8.

Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.

Pinola P, Lashen H, Bloigu A, Puukka K, Ulmanen M, Ruokonen A, Martikainen H, Pouta A, Franks S, Hartikainen AL, Järvelin MR, Morin-Papunen L.

Hum Reprod. 2012 Nov;27(11):3279-86. doi: 10.1093/humrep/des309. Epub 2012 Aug 29.

PMID:
22933528
9.

Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls.

Chhabra S, McCartney CR, Yoo RY, Eagleson CA, Chang RJ, Marshall JC.

J Clin Endocrinol Metab. 2005 May;90(5):2810-5. Epub 2005 Feb 22.

PMID:
15728200
10.

Acceleration of luteinizing hormone pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism.

Escobar ME, Ropelato MG, Ballerini MG, Gryngarten MG, Rudaz MC, Veldhuis JD, Barontini M.

Horm Res. 2007;68(6):278-85. Epub 2007 Jun 20.

PMID:
17587857
11.

Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.

Alemzadeh R, Kichler J, Calhoun M.

Eur J Endocrinol. 2010 Jun;162(6):1093-9. doi: 10.1530/EJE-10-0205. Epub 2010 Apr 6.

12.

Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.

Gambineri A, Patton L, De Iasio R, Palladoro F, Pagotto U, Pasquali R.

J Clin Endocrinol Metab. 2007 Jun;92(6):2066-73. Epub 2007 Mar 13.

PMID:
17356050
13.

Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.

West S, Lashen H, Bloigu A, Franks S, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Morin-Papunen L.

Hum Reprod. 2014 Oct 10;29(10):2339-51. doi: 10.1093/humrep/deu200. Epub 2014 Aug 1.

14.

Insulin and the polycystic ovary syndrome.

Utiger RD.

N Engl J Med. 1996 Aug 29;335(9):657-8. No abstract available.

PMID:
8687522
15.
16.

[Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].

Ságodi L, Lombay B, Vámosi I, Barkai L.

Orv Hetil. 2013 Aug 4;154(31):1226-34. doi: 10.1556/OH.2013.29669. Hungarian.

PMID:
23895991
17.

Adolescent polycystic ovary syndrome.

Connor EL.

Adolesc Med State Art Rev. 2012 Apr;23(1):164-77, xii. Review.

PMID:
22764561
18.
19.

Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.

McCartney CR, Eagleson CA, Marshall JC.

Semin Reprod Med. 2002 Nov;20(4):317-26. Review.

PMID:
12536355
20.

Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization.

Filicori M.

Clin Obstet Gynecol. 1993 Sep;36(3):737-43. Review. No abstract available.

PMID:
8403620

Supplemental Content

Support Center